Cerebral Venous Thrombosis Cohort Study in China Mainland
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCapital Medical University
About this trial
This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients with cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Death rate
A combination of death form of all causes
Time frame
1 year from baseline2
Functional independence
Defined as modified Rankin score (0-5) equal to or lower than 2
Time frame
1 year from baseline3
Recurrence of cerebral venous sinus thrombosis, deep cerebral venous thrombosis and cortical vein thrombosis
Diagnosed by DSA, MRV, CTV or HR-MRI
Time frame
1 year from baseline4
Incidence of hemorrhagic complication
Extracranial hemorrhage (fall in hemoglobin of 2 gram/dl or more within 48 hours) or intracranial hemorrhage
Time frame
1 year from baselineSecondary outcomes
1
Incidence of epilepsy
Time frame
1 year from baseline2
Incidence of allergic reaction
Time frame
1 year from baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Capital Medical University
Lead sponsor
Beijing Municipal Science & Technology Commission
Collaborator
Source ClinicalTrials.gov